All lobbying filings

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Lobbying for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION · patient advocacy organization for individuals suffering from a rare disease

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $10,000.00 income · posted Jul 17, 2026

Official filing document

Bills named in this filing 2

HR 9495
Department of Defense Appropriations Act, 2027
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Lobbying activity 2

Defense

H.R. 9495/S Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT)

Health Issues

H.R. 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R. 9260/S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.